PF-4136309
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-4136309, covering 2023-07-27 to 2023-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes [Phase 2]